CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
Sang Haak Lee, Chin Kook Rhee, Kwangha Yoo, Jeong Woong Park, Suk Joong Yong, Jusang Kim, Taehoon Lee, Seong Yong Lim, Ji-Hyun Lee, Hye Yun Park, Minyoung Moon, Ki-Suck Jung
Tuberc Respir Dis. 2021;84(2):96-104.   Published online December 22, 2020
DOI: https://doi.org/10.4046/trd.2020.0109

Excel Download

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
Sang Haak Lee, Chin Kook Rhee, Kwangha Yoo, Jeong Woong Park, Suk Joong Yong, Jusang Kim, Taehoon Lee, Seong Yong Lim, Ji-Hyun Lee, Hye Yun Park, Minyoung Moon, Ki-Suck Jung
Tuberculosis and Respiratory Diseases. 2021;84(2):96-104   Crossref logo
Link1 Link2 Link3
Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
Charlotte Ulrik
International Journal of Chronic Obstructive Pulmonary Disease. 2014;331   Crossref logo
Link1
EFFICACY AND SAFETY OF SWITCH FROM TIOTROPIUM TO INDACATEROL/GLYCOPYRRONIUM IN SYMPTOMATIC MILD‐TO‐MODERATE COPD PATIENTS FROM KOREA: A RANDOMIZED, OPEN‐LABEL, 12‐WEEK TRIAL
Respirology. 2018;23(S2):136-136   Crossref logo
Link1 Link2
The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study
Peter Kardos, Ina Hagedorn-Peinz
International Journal of Chronic Obstructive Pulmonary Disease. 2017;Volume 13:69-77   Crossref logo
Link1 Link2
Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program
Ioanna Tsiligianni, Karen Mezzi, Sebastian Fucile, Konstantinos Kostikas, Steven Shen, Donald Banerji, Robert Fogel
COPD: Journal of Chronic Obstructive Pulmonary Disease. 2017;14(4):375-381   Crossref logo
Link1 Link2
QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease
James E. Frampton
Drugs. 2014;74(4):465-488   Crossref logo
Link1 Link2 Link3
Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
Walter Vincken, Joseph Aumann, Hungta Chen, Michelle Henley, Danny McBryan, Pankaj Goyal
International Journal of Chronic Obstructive Pulmonary Disease. 2014;215   Crossref logo
Link1
<p>Real-life effectiveness of indacaterol&ndash;glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p>
Alan Kaplan, Kenneth R. Chapman, Syed M. Anees, Irvin Mayers, Driss Rochdi, Michel Djandji, David Préfontaine, Andrew McIvor
International Journal of Chronic Obstructive Pulmonary Disease. 2019;Volume 14:249-260   Crossref logo
Link1 Link2
Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease
Naoki Inui, Sayomi Matsushima, Shinpei Kato, Hideki Yasui, Masato Kohno, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Mikio Toyoshima, Takafumi Suda
International Journal of Chronic Obstructive Pulmonary Disease. 2015;1139   Crossref logo
Link1
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol
Gregory Feldman
International Journal of Chronic Obstructive Pulmonary Disease. 2013;89   Crossref logo
Link1